Inventor · disambiguated record
Chu-Hsun Lu
Also filed as: LU CHU-HSUN
12 granted patents·5 pending applications·13 citations·filing 2002–2023
84Inventor score
Top patents by PatentIndex Score
17 records- 0187US11701399B2Composition for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseases, and method for modulating intestinal permeability and/or treating and/or preventing leaky gut related diseasesIND TECH RES INST·Filed 2020·Granted Jul 18, 2023·2 cites·9 claims
- 0271US10987394B2Method for preparing an extract of Chrysanthemum morifolium with an effect of treating skin diseases, extract of Chrysanthemum morifolium with an effect of treating skin diseases and pharmaceutical composition containing the extractIND TECH RES INST·Filed 2017·Granted Apr 27, 2021·1 cites·36 claims
- 0370US12226441B2Composition for inhibiting intestinal permeability, treating leaky gut related diseases and/or preventing leaky gut related diseasesIND TECH RES INST·Filed 2023·Granted Feb 18, 2025·0 cites·14 claims
- 0467US7799353B2Pharmaceutical mixture for hepatitis treatment and its preparation methodIND TECH RES INST·Filed 2008·Granted Sep 21, 2010·1 cites·11 claims
- 0567US6635758B2Process for extracting glycoside using an aqueous two-phase systemIND TECH RES INST·Filed 2002·Granted Oct 21, 2003·5 cites·37 claims
- 0666US12433924B2Pharmaceutical composition or health food for treating and/or alleviating nervous diseasesIND TECH RES INST·Filed 2021·Granted Oct 7, 2025·0 cites·8 claims
- 0765US7431946B2Method for producing extracts of Boehmeria frutescens thunberg or Boehmeria nivea for hepatitis treatmentIND TECH RES INST·Filed 2004·Granted Oct 7, 2008·4 cites·15 claims
- 0860US2022249395A1Pharmaceutical formulations for a liquid dosage form and a controlled release dosage formIND TECH RES INST·Filed 2022·Application pending·0 cites
- 0958US10821148B2Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritisIND TECH RES INST·Filed 2017·Granted Nov 3, 2020·0 cites·8 claims
- 1055US11400054B2Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage formIND TECH RES INST·Filed 2018·Granted Aug 2, 2022·0 cites·9 claims
- 1154US12128082B2Method for extracting flavone aglycones in chrysanthemum morifolium, extract obtained thereby and anti-inflammatory pharmaceutical compositionIND TECH RES INST·Filed 2021·Granted Oct 29, 2024·0 cites·18 claims
- 1254US2021015882A1Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritisIND TECH RES INST·Filed 2020·Application pending·0 cites
- 1352US2021290557A1Multi-particulate pharmaceutical composition, immediate release pellets, sustained release pellets, enteric release pellets and use thereofIND TECH RES INST·Filed 2020·Application pending·0 cites
- 1451US11083762B2Application for water extract of plant of Gracilariaceae or ferment thereof and pharmaceutical composition and/or health food for treating and/or alleviating nervous diseasesIND TECH RES INST·Filed 2017·Granted Aug 10, 2021·0 cites·8 claims
- 1546US2009280200A1Herbal extracts which induce immune cells to produce interferon and activate toll-like receptorsIND TECH RES INST·Filed 2008·Application pending·0 cites
- 1645US7150886B2Composition for treating diseased liverIND TECH RES INST·Filed 2003·Granted Dec 19, 2006·0 cites·29 claims
- 1744US2013059382A1Biomedical materials for tissue engineeringTSAI PEI-YI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chu-Hsun Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →